Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Depreciation & Amortization (CF): 2010-2024

Historic Depreciation & Amortization (CF) for Nutex Health (NUTX) over the last 15 years, with FY2024 value amounting to $19.0 million.

  • Nutex Health's Depreciation & Amortization (CF) rose 62.35% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.6 million, marking a year-over-year increase of 1224.71%. This contributed to the annual value of $19.0 million for FY2024, which is 784.69% up from last year.
  • Latest data reveals that Nutex Health reported Depreciation & Amortization (CF) of $19.0 million as of FY2024, which was up 784.69% from $17.6 million recorded in FY2023.
  • Nutex Health's 5-year Depreciation & Amortization (CF) high stood at $19.0 million for FY2024, and its period low was $5.9 million during FY2020.
  • For the 5-year period, Nutex Health's Depreciation & Amortization (CF) averaged around $12.7 million, with its median value being $13.1 million (2022).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 367877.21% in 2020, then skyrocketed by 784.69% in 2024.
  • Nutex Health's Depreciation & Amortization (CF) (Annual) stood at $5.9 million in 2020, then rose by 29.91% to $7.7 million in 2021, then surged by 71.37% to $13.1 million in 2022, then surged by 33.97% to $17.6 million in 2023, then grew by 7.85% to $19.0 million in 2024.
  • Its Depreciation & Amortization (CF) stands at $19.0 million for FY2024, versus $17.6 million for FY2023 and $13.1 million for FY2022.